<?xml version="1.0" encoding="UTF-8"?>
<p>The standard pharmacological therapy to replace dopamine with levo-dihydroxyphenylalanine (L-DOPA), although initially effective, gradually produces tolerance, as do other dopamine-linked drugs. Together with the progressive course of the disease these drugs cause motor side effects (motor fluctuations, dyskinesias, and wearing-off phenomena)
 <sup>
  <xref rid="bibr9-0963689718820271" ref-type="bibr">9</xref>,
  <xref rid="bibr10-0963689718820271" ref-type="bibr">10</xref>
 </sup> that can become as crippling as PD motor symptoms themselves. When PD becomes drug resistant, deep brain stimulation (DBS) in the subthalamic nucleus or globus pallidus
 <sup>
  <xref rid="bibr11-0963689718820271" ref-type="bibr">11</xref>,
  <xref rid="bibr12-0963689718820271" ref-type="bibr">12</xref>
 </sup> is an alternative neurosurgical treatment available for PD. However, DBS is yet another symptomatic treatment of PD. Not until we know the events that trigger the degenerative processes of PD will it be possible to design a cure for the disease
 <sup>
  <xref rid="bibr13-0963689718820271" ref-type="bibr">13</xref>
 </sup>.
</p>
